• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biohaven Ltd (NY: BHVN )

    37.81 +1.36 (+3.73%)
    Official Closing Price Updated: 7:00 PM EDT, Jul 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 904,496
    Open 36.32
    Bid (Size) 36.72 (1)
    Ask (Size) 39.26 (1)
    Prev. Close 36.45
    Today's Range 35.80 - 37.97
    52wk Range 16.45 - 62.21
    Shares Outstanding 65,401,228
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    $1M Bet On Biohaven? Check Out These 3 Stocks Insiders Are Buying
    Via Benzinga
    The 3 Smartest Healthcare Stocks to Buy With $1K Right Now
    The healthcare stocks to buy deserve more respect from investors who seek top-level growth outside of the tech sector. 
    Via InvestorPlace

    Performance

    YTD
    -9.83%
    -9.83%
    1 Month
    +8.84%
    +8.84%
    3 Month
    -4.54%
    -4.54%
    6 Month
    -21.73%
    -21.73%
    1 Year
    +58.67%
    +58.67%

    More News

    Read More
    HP Posts Upbeat Earnings, Joins Foot Locker, American Superconductor, Red Robin Gourmet Burgers And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    After Biohaven Kerfuffle, Immunovant Dives On A Surprise Delay
    Via Investor's Business Daily
    Biohaven Stock Stumbles As Protein-Degrading Drug Falls Short Of Expectations In Early-Stage Study
    Via Benzinga
    BHVN Stock Earnings: Biohaven Misses EPS for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    What's Going On With Biohaven Stock Wednesday?
    Via Benzinga
    Biohaven Crashes After Protein-Degrading Drug Misses Expectations; Immunovant, Argenx Jump
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan
    Via Benzinga
    Sony Group Posts Upbeat Earnings, Joins GameStop, Paysafe And Other Big Stocks Moving Higher On Tuesday
    Via Benzinga
    Crocs To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
    Via InvestorPlace
    Around $1M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying
    Via Benzinga
    3 Biotech Stocks to Buy on the Dip: April 2024
    Via InvestorPlace
    Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Is Obesity Drug Developer Altimmune Stock Trading Lower On Wednesday?
    Via Benzinga
    Obesity Drug Landscape Has A Contender From Biohaven, CEO Highlights Different Approach Amid Stiff Competition From Novo Nordisk, Eli Lilly
    Via Benzinga
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 3/8
    Via Investor Brand Network
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 3/4
    Via Investor Brand Network
    Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
    Via Investor's Business Daily
    This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
    Via Benzinga
    Stocks to Watch: 3 Companies Working on Next-Gen Weight Loss Drugs
    Via InvestorPlace
    Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) is a Stock Spotlight on 1/5
    Via Investor Brand Network
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.